Cormedix

PriceCormedix

CRMD

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company’s focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Historical stock price chart and annual return over the past years

80%

5 years

% Total

CRMD
13%

5 years

Annual Return

CRMD